Steris PLC (NYSE:STE) Director Richard Martin Steeves sold 5,854 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $153.77, for a total value of $900,169.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Richard Martin Steeves also recently made the following trade(s):
- On Monday, December 2nd, Richard Martin Steeves sold 5,960 shares of Steris stock. The stock was sold at an average price of $150.75, for a total value of $898,470.00.
NYSE STE traded up $1.99 during trading hours on Wednesday, hitting $154.07. The company’s stock had a trading volume of 471,410 shares, compared to its average volume of 469,005. Steris PLC has a 52 week low of $99.14 and a 52 week high of $156.66. The company has a market capitalization of $12.81 billion, a PE ratio of 31.51 and a beta of 0.89. The company has a current ratio of 2.41, a quick ratio of 1.86 and a debt-to-equity ratio of 0.73. The company’s 50-day simple moving average is $145.59 and its two-hundred day simple moving average is $145.58.
Steris (NYSE:STE) last issued its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $736.84 million during the quarter, compared to analyst estimates of $717.79 million. Steris had a return on equity of 16.15% and a net margin of 11.59%. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.10 EPS. Research analysts anticipate that Steris PLC will post 5.6 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Tuesday, November 26th will be given a dividend of $0.37 per share. The ex-dividend date of this dividend is Monday, November 25th. This represents a $1.48 annualized dividend and a dividend yield of 0.96%. Steris’s payout ratio is 30.27%.
Separately, ValuEngine cut Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $148.20.
A number of institutional investors have recently made changes to their positions in STE. TrinityPoint Wealth LLC boosted its holdings in Steris by 3.4% during the second quarter. TrinityPoint Wealth LLC now owns 2,267 shares of the medical equipment provider’s stock worth $336,000 after purchasing an additional 75 shares during the last quarter. CWM LLC boosted its stake in shares of Steris by 130.9% in the 3rd quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock worth $27,000 after buying an additional 106 shares during the last quarter. Parallel Advisors LLC boosted its stake in shares of Steris by 7.6% in the 3rd quarter. Parallel Advisors LLC now owns 1,664 shares of the medical equipment provider’s stock worth $240,000 after buying an additional 117 shares during the last quarter. Squar Milner Financial Services LLC boosted its stake in shares of Steris by 225.9% in the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 122 shares during the last quarter. Finally, Cullen Frost Bankers Inc. grew its holdings in shares of Steris by 114.4% in the second quarter. Cullen Frost Bankers Inc. now owns 253 shares of the medical equipment provider’s stock valued at $38,000 after acquiring an additional 135 shares in the last quarter. Institutional investors and hedge funds own 86.77% of the company’s stock.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Further Reading: How Investors Can Profit from Options Trading
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.